Rare Warning Letter Cites Alphatec For Post-Market Study Non-Compliance

FDA warned spinal implant and surgical instrument developer Alphatec Spine that failing to meet mandatory post-market study requirements for three 510(k)-cleared spine devices makes the products misbranded under the law.

More from Archive

More from Medtech Insight